Enabling Continuous Wearable Reflectance Pulse Oximetry at the Sternum

In light of the recent Coronavirus disease (COVID-19) pandemic, peripheral oxygen saturation (SpO₂) has shown to be amongst the vital signs most indicative of deterioration in persons with COVID-19. To allow for the continuous monitoring of SpO₂, we attempted to demonstrate accurate SpO₂ estimation using our custom chest-based wearable patch biosensor, capable of measuring electrocardiogram (ECG) and photoplethysmogram (PPG) signals with high fidelity. Through a breath-hold protocol, we collected physiological data with a wide dynamic range of SpO₂ from 20 subjects. The ratio of ratios (R) used in pulse oximetry to estimate SpO₂ was robustly extracted from the red and infrared PPG signals during the breath-hold segments using novel feature extraction and PPG_green-based outlier rejection algorithms. Through subject independent training, we achieved a low root-mean-square error (RMSE) of 2.64 ± 1.14% and a Pearson correlation coefficient (PCC) of 0.89. With subject-specific calibration, we further reduced the RMSE to 2.27 ± 0.76% and increased the PCC to 0.91. In addition, we showed that calibration is more efficiently accomplished by standardizing and focusing on the duration of breath-hold rather than the resulting range in SpO₂. The accurate SpO₂ estimation provided by our custom biosensor and the algorithms provide research opportunities for a wide range of disease and wellness monitoring applications.

Development and clinical evaluation of a new sensor design for buccal pulse oximetry in horses

BACKGROUND

The use of pulse oximetry in horses is limited due to inadequate readings with conventional transmission sensor probes.

OBJECTIVES

The objectives of this study were to 1) develop an improved sensor design for horses to be used at an appropriate anatomical site, and 2) evaluate this design in an experimental study.

STUDY DESIGN

In vivo experiment.

METHODS

A new sensor design for reflectance pulse oximetry at the buccal mucosa was developed. A conventional Nonin 2000SL sensor for transmission pulse oximetry was included into this design. Three different prototypes (N1, N2a, N2b) were constructed and used with the Nonin 2500A Vet pulse oximetry monitor. Thirteen anaesthetised warmblood horses were included into a desaturation protocol (100-70% SaO₂ ). SpO₂ and pulse frequency values were recorded, using SaO₂ calculated from blood gas analysis and invasive pulse frequency measurements as reference methods. Bias and precision were evaluated by calculations of the root mean square deviation (A_rms ). The agreement of the methods was tested with Bland-Altman analysis.

RESULTS

The quality of the pulse frequency readings determined the quality of the SpO₂ -readings. Good pulse signal strength resulted in a SpO₂ -accuracy comparable to that of the original sensor (Nonin 2000SL: A_rms = 3%; N1: A_rms = 3.60%; N2b: A_rms = 3.46%). Especially at heart rates ≤30 bpm, pulse rate readings that were about twice as high as the reference value occurred. Their exclusion from the dataset resulted in a pulse rate accuracy similar to that of the original sensor. Bland-Altman plots showed limits of agreement typical of pulse oximeters.

MAIN LIMITATIONS

The pulse frequency accuracy requires further improvement. The usability in clinical cases needs to be tested.

CONCLUSIONS

The new sensor design has been shown to be suitable for buccal pulse oximetry in horses.

Phantom with pulsatile arteries to investigate the influence of blood vessel depth on pulse oximeter signal strength

This paper describes a three-layer head phantom with artificial pulsating arteries at five different depths (1.2 mm, 3.7 mm, 6.8 mm, 9.6 mm and 11.8 mm). The structure enables formation of spatially and temporally varying tissue properties similar to those of living tissues. In our experiment, pressure pulses were generated in the arteries by an electronically controlled pump. The physical and optical parameters of the layers and the liquid in the artificial arteries were similar to those of real tissues and blood. The amplitude of the pulsating component of the light returning from the phantom tissues was measured at each artery depth mentioned above. The build-up of the in-house-developed pulse oximeter used for performing the measurements and the physical layout of the measuring head are described. The radiant flux generated by the LED on the measuring head was measured to be 1.8 mW at 910 nm. The backscattered radiant flux was measured, and found to be 0.46 nW (0.26 ppm), 0.55 nW (0.31 ppm), and 0.18 nW (0.10 ppm) for the 1.2 mm, 3.7 mm and 6.8 mm arteries, respectively. In the case of the 9.6 mm and 11.8 mm arteries, useful measurement data were not obtained owing to weak signals. We simulated the phantom with the arteries at the above-mentioned five depths and at two additional ones (2.5 mm and 5.3 mm in depth) using the Monte Carlo method. The measurement results were verified by the simulation results. We concluded that in case of 11 mm source-detector separation the arteries at a depth of about 2.5 mm generate the strongest pulse oximeter signal level in a tissue system comprising three layers of thicknesses: 1.5 mm (skin), 5.0 mm (skull), and >50 mm (brain).